Core Insights - Four Seasons Pharmaceutical (00460) has signed an investment subscription agreement to acquire a stake in Swiss medical aesthetics company Suisselle SA, aiming to enhance their strategic relationship and expand in the global medical aesthetics market [1][2] - The company previously secured exclusive agency rights for the CELLBOOSTER water needle in China in 2022, and this investment will solidify their long-term partnership, granting permanent exclusive agency rights for the product [1] - The collaboration will leverage Suisselle's established platform in Europe to accelerate the promotion and sales of the company's self-developed medical aesthetic products in Europe and other overseas markets [1] - The investment aligns with the company's globalization strategy, aiming to build an international medical aesthetics ecosystem covering research, production, and sales [1] Strategic Developments - The company has been actively pursuing a global strategy in the medical aesthetics sector, having fully acquired American medical aesthetics equipment company Genesis Biosystems in 2021, marking its entry into the North American market [2] - The investment in Suisselle represents a critical step in the company's global strategy, completing its strategic layout in the core medical aesthetics markets of Europe and North America [2] - The company plans to continue driving high-quality medical aesthetic solutions through a dual approach of independent research and international collaboration, aiming to create long-term sustainable value for shareholders and investors [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 告 全部或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責 任。 Sihuan Pharmaceutical Holdings Group Ltd. 四環醫藥控股集團有限公司 （於百慕達註冊成立的有限公司） （股份代號：0460） 自願公告 四環醫藥投資入股瑞士Suisselle公 司 加速全球化醫美業務布局 CELLBOOSTER®為瑞士制造的創新水光針（歐洲III類醫療器械），憑借其專利CHAC 技 術 實 現 成 分 穩 定 與 高 效 遞 送，涵 蓋 多 維 度 皮 膚 問 題 解 決 方 案： 四 環 醫 藥 控 股 集 團 有 限 公 司（「本公司」或「四環醫藥」，連 同 其 附 屬 公 司，統 稱 為 「本集團」）董 事 會（「董事會」）欣 然 宣 佈，本 集 團 於 二 零 二 五 年 九 月 對 瑞 士 醫 美 公 司Suisselle SA（「Suisselle」）進 行 投 資 入 股，雙 ...